Drugs / Five phage anti-Staphylococcus aureus bacteriophage cocktail
Five phage anti-Staphylococcus aureus bacteriophage cocktail
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07461337 | Mar 2026 → Mar 2027 expected | periprosthetic joint infection | University of Calgary | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Five phage anti-Staphylococcus aureus bacteriophage cocktail | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07461337 ↗ |
| Modality | Other / unclassified | “bacteriophage drug product” NCT07461337 ↗ |